DBV TECHNOLOGIES (EPA:DBV)

PRESS RELEASE

published on 07/29/2024 at 07:30, 3 months 23 days ago

DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
DBV Technologies to host conference call and webcast to review second quarter 2024 financial results and business update on July 30, 2024. Focus on food allergy treatments

Financial Results Conference Call Immunotherapy DBV Technologies Food Allergies
BRIEF

published on 07/08/2024 at 22:35, 4 months 12 days ago

Half-yearly review of the DBV Technologies liquidity contract with ODDO BHF

Liquidity Contract ODDO BHF Stock Transactions DBV Technologies Half-yearly Review
PRESS RELEASE

published on 07/08/2024 at 22:30, 4 months 12 days ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
DBV Technologies issues Half-Year Report on Liquidity Contract with ODDO BHF, revealing assets and transaction details for the period

Liquidity Contract Transactions Half-year Report ODDO BHF DBV Technologies
BRIEF

published on 06/05/2024 at 22:35, 5 months 15 days ago

DBV Technologies to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Investors DBV Technologies Viaskin Goldman Sachs Global Healthcare Conference Daniel Tassé
PRESS RELEASE

published on 06/05/2024 at 22:30, 5 months 15 days ago

DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
DBV Technologies to participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10th, featuring CEO Daniel Tassé in a fireside chat and investor meetings. Live webcast available online

Biopharmaceutical DBV Technologies Food Allergies Goldman Sachs Global Healthcare Conference Daniel Tassé
BRIEF

published on 06/04/2024 at 22:35, 5 months 16 days ago

DBV Technologies Reports Voting Rights and Shares Information as of May 31, 2024

Voting Rights Shares AMF Regulations DBV Technologies
PRESS RELEASE

published on 06/04/2024 at 22:30, 5 months 16 days ago

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
Press release providing information on the total number of voting rights and shares of the Company as of May 31, 2024, in compliance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers

Voting Rights Shares AMF Company NYSE Euronext Paris
BRIEF

published on 05/31/2024 at 15:56, 5 months 21 days ago

DBV Technologies Announces Plan to Implement ADS Ratio Change

Nasdaq Compliance Biopharmaceutical Reverse Split DBV Technologies ADS Ratio
PRESS RELEASE

published on 05/31/2024 at 15:51, 5 months 21 days ago

DBV Technologies Announces Plan to Implement ADS Ratio Change
DBV Technologies announces plan to change ADS Ratio to regain Nasdaq compliance effective June 7th, 2024, impacting ADS holders trading price

Biopharmaceutical Company Nasdaq Compliance DBV Technologies ADS Ratio Change Food Allergies Treatment
BRIEF

published on 05/17/2024 at 22:35, 6 months 3 days ago

DBV Technologies Announces ADS Ratio Change

Nasdaq Compliance Biopharmaceuticals Stock Adjustment DBV Technologies ADS Ratio Change

Published on 11/21/2024 at 16:30, 37 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 6 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 26 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 45 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 9 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 21 hours 47 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 23 hours 22 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 23 hours 22 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 9 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE

News